CorMedix (CRMD)

• Market cap: $391M
• 1 day: 2.39%
• 5 days: -1.32%
• 1 month: -43.98%
• 3 months: -41.75%
• 6 months: -34.57%
• Year to date: -27.01%
• 1 year: 26.05%
• 5 years: 86.34%
• 10 years: -87.01%
• Sector: Healthcare
• Industry: Biotechnology

Fund manager confidence

Based on 2024 Q4 regulatory disclosures by fund managers ($100M+ AUM)

264% more first-time investments, than exits

New positions opened: 40 | Existing positions closed: 11

92% more repeat investments, than reductions

Existing positions increased: 48 | Existing positions reduced: 25

66% more call options, than puts

Call options by funds: $6.64M | Put options by funds: $4M

26% more funds holding

Funds holding: 102 [Q3] → 129 (+27) [Q4]

19% more capital invested

Capital invested by funds: $156M [Q3] → $186M (+$29.8M) [Q4]

3.2% more ownership

Funds ownership: 34.63% [Q3] → 37.83% (+3.2%) [Q4]

50% less funds holding in top 10

Funds holding in top 10: 2 [Q3] → 1 (-1) [Q4]

Research analyst outlook

4 Wall Street Analysts provided 1 year price targets over the past 3 months

• Low target: $12 100% upside
• Avg. target: $14.25 138% upside
• High target: $18 200% upside

4 analyst ratings

• positive: 4 100%
• neutral: 0 0%
• negative: 0 0%

RBC Capital Gregory Renza 27% 1-year accuracy 20 / 74 met price target	100% upside $12	Outperform Reiterated	26 Mar 2025
Needham Serge Belanger 34% 1-year accuracy 38 / 112 met price target	100% upside $12	Buy Maintained	26 Mar 2025
D. Boral Capital Jason Kolbert 22% 1-year accuracy 73 / 333 met price target	150% upside $15	Buy Maintained	25 Mar 2025
Leerink Partners Roanna Ruiz 25% 1-year accuracy 2 / 8 met price target	200% upside $18	Outperform Initiated	7 Mar 2025